Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

InVitae

Explore full profile

Bringing comprehensive, affordable, expert genetic insights into mainstream medical care. To read our community guidelines, visit https://t.co/mWqD4UMDer

San Francisco, United StatesFounded 2010Biotech & Life Sciences
Valuation $1.28B Market cap · 2026
Revenue $487M Latest reported FY

At a glance

Founded
2010
Headquarters
San Francisco, United States
Listing
IPO 2015
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Anya Schiess

Series B and later11 investors entered at this stage

Talent

Book a demo to see the people
Employees mapped 678 incl. 19 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 13 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 11 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 of 11 startups shown

Former InVitae employees who went on to found companies, sorted by Dealroom signal score.

e-LōvuEst. 2022
KGKamal GogineniUnited States
Signal score82
Nest GenomicsEst. 2022
GSGuy SnirUnited States
Signal score78
Xili TechnologyEst. 2021
YLYang LiUnited States
Signal score75
JustPaidEst. 2022
Vinay PinnakaUnited States
Signal score72
Enumera MolecularEst. 2022
KJKevin B JacobsUnited States
Signal score70
6 more alumni-founded companies in this previewBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
14 countries with
team presence
🇺🇸 United States95.7%
🇦🇺 Australia0.6%
🇵🇭 Philippines0.6%
🇧🇷 Brazil0.4%
🇷🇸 Serbia0.2%
Top 5 of 14 shown
Web traffic by country
410K monthly visits
across markets
🇺🇸 United States91%
🇨🇦 Canada1.5%
🇦🇺 Australia1.1%
🇿🇦 South Africa0.7%
🇬🇧 United Kingdom0.5%
Top 5 markets shown

Patents

Estimated portfolio value
$110M

151 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where InVitae was the backer or acquirer, 2017–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

8 deals across InVitae's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where InVitae deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        InVitae's portfolio, mapped.

        Stage
        Period
        8 of 8 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about InVitae on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See InVitae on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles